SOLIFENACIN+TAMSULOSIN OCAS

10mg; 15mg; 20mg coated tablets

5mg/100mg; 10mg/100mg; 20mg/100mg capsules

Treatment of myelofibrosis (intermediate/high-risk), polycythaemia vera (resistant/intolerant to hydroxyurea), and steroid-refractory acute or chronic Graft-versus-Host Disease.

 25mg; 50mg; 100mg coated tablets (25mg; 50mg also available as OTC)

25mg; 50mg; 100mg coated tablets

50mg/500mg
50mg/1000mg
100mg/1000mg
ER tablets

Treatment of hypertension, particularly in patients requiring multiple drugs to achieve blood pressure control

Smoking cessation aid to reduce nicotine withdrawal symptoms and cravings associated with quitting smoking.

Treatment of hypercholesterolemia to lower total cholesterol and LDL cholesterol levels

5 % foam, Minoxidil, as a vasodilator, increases microcirculation in the hair follicles and stimulates Vascular Endothelial Growth Factor (VEGF), which is possibly responsible for increased capillary permeability and thus a potent metabolic activity in the anagen phase, which:
•increases the d...

375mg, 500mg, 750mg extended release tablets, Ranolazine is a selective inhibitor of the late inward sodium current. Inhibiting that current leads to reductions in intracellular calcium levels. It is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angi...

5mg; 10mg; 15mg; 20mg orodispersible tablets

Adamd`s Product Portfolio

Davipharm is a member of the Adamed group. Produced in Vietnam with EU GMP standards. The export products' list to non-stringent & stringent markets. Contact us

Presentation

The history of Adamed is about responding to thekey challenges of modern medicine. This is both ourmission and the direction we have consistently takensince 1986. Every day, we work with numerousscientists on innovative research projects aimed atimproving existing therapies and promoting diseaseprevention and a healthy lifestyle. To achieve ourgoals, we employ the best specialists in the countryand collaborate with leading scientific centres andinstitutions, while employing state-of-the-art technologiesin all areas of our operations.All this makes Adamed a leader in the next-generationpharmaceutical market in Poland. Our productsare available in dozens of markets all over theworld. Even with this success, we have no intentionof resting on our laurels. We continue to evolve andto search for inspiration and unconventional solutions.We encourage you to learn more about AdamedPharma – the place where Polish innovation begins.

This is where Polish innovation begins